UY26296A1 - Tratamiento medicamentoso del síndrome de piernas inquietas - Google Patents
Tratamiento medicamentoso del síndrome de piernas inquietasInfo
- Publication number
- UY26296A1 UY26296A1 UY26296A UY26296A UY26296A1 UY 26296 A1 UY26296 A1 UY 26296A1 UY 26296 A UY26296 A UY 26296A UY 26296 A UY26296 A UY 26296A UY 26296 A1 UY26296 A1 UY 26296A1
- Authority
- UY
- Uruguay
- Prior art keywords
- legs syndrome
- inquiet
- drug treatment
- rls
- monotherapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
El invento se refiere a una nueva combinación de sutancias activas para el tratamiento más eficaz del síndrome de piernas inquietas (RLS), que consta de un agente agonista alfa 2 y de otro neuro-psicofármaco que reduce los síntomas del RLS como una monoterapia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19938823A DE19938823A1 (de) | 1999-08-19 | 1999-08-19 | Medikamentöse Behandlung des Restless Leg Syndroms |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26296A1 true UY26296A1 (es) | 2001-04-30 |
Family
ID=7918572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26296A UY26296A1 (es) | 1999-08-19 | 2000-08-16 | Tratamiento medicamentoso del síndrome de piernas inquietas |
Country Status (21)
Country | Link |
---|---|
US (1) | US20010053777A1 (es) |
EP (1) | EP1210076A2 (es) |
JP (1) | JP2003513014A (es) |
KR (1) | KR20020020273A (es) |
CN (1) | CN1368878A (es) |
AR (1) | AR025329A1 (es) |
AU (1) | AU6836500A (es) |
BR (1) | BR0013355A (es) |
CA (1) | CA2382648A1 (es) |
CO (1) | CO5190708A1 (es) |
CZ (1) | CZ2002516A3 (es) |
DE (1) | DE19938823A1 (es) |
IL (1) | IL147643A0 (es) |
MX (1) | MXPA02001295A (es) |
NO (1) | NO20020792D0 (es) |
PE (1) | PE20010738A1 (es) |
PL (1) | PL364871A1 (es) |
SK (1) | SK2452002A3 (es) |
TR (1) | TR200200450T2 (es) |
UY (1) | UY26296A1 (es) |
WO (1) | WO2001013903A2 (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
HU1500214D0 (hu) | 1997-12-22 | 2002-03-28 | Euro Celtique Sa | Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény |
EP1274430B1 (en) * | 2000-04-21 | 2005-12-14 | Pharmacia & Upjohn Company LLC | Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome |
CA2404704A1 (en) * | 2000-04-21 | 2001-11-22 | David W. Robertson | Treatment of fibromyalgia and chronic fatigue syndrome |
DE10053397A1 (de) * | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
DE10041479A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
AR031152A1 (es) | 2000-10-31 | 2003-09-10 | Upjohn Co | Tratamientos nuevos para el sindrome de piernas inquietas |
PT1380306E (pt) * | 2001-03-30 | 2009-05-25 | Toray Industries | Medicamentos para psiconeurose |
WO2002083141A1 (en) * | 2001-04-17 | 2002-10-24 | Pharmacia & Upjohn Company | Treatment of fibromyalgia and chronic fatigue syndrome |
ES2361148T3 (es) | 2001-05-11 | 2011-06-14 | Endo Pharmaceuticals Inc. | Forma de dosificación de opioides de liberación controlada resistente al abuso. |
US20030073609A1 (en) * | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US20060263419A1 (en) * | 2002-03-12 | 2006-11-23 | Hans-Michael Wolff | Transdermal therapeutic system for Parkinson's Disease |
EP2425823A1 (en) | 2002-04-05 | 2012-03-07 | Euro-Celtique S.A. | Pharmaceutical preparation containing oxycodone and naloxone |
DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
AU2003257418A1 (en) * | 2002-06-19 | 2004-01-06 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
US8246979B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
ATE295726T1 (de) | 2002-12-02 | 2005-06-15 | Sanol Arznei Schwarz Gmbh | Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese |
DE10338174A1 (de) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
EP1604667A1 (en) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the restless leg syndrome |
EP1604666A1 (en) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
JP5704789B2 (ja) * | 2005-01-28 | 2015-04-22 | ユーロ−セルティーク エス.エイ. | 耐アルコール性剤形 |
EP1702558A1 (en) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
EP1695700A1 (en) * | 2005-02-28 | 2006-08-30 | Euro-Celtique S.A. | Dosage form containing oxycodone and naloxone |
EP1813276A1 (en) * | 2006-01-27 | 2007-08-01 | Euro-Celtique S.A. | Tamper resistant dosage forms |
JP5769923B2 (ja) | 2006-04-03 | 2015-08-26 | テバ ファーマシューティカル インダストリーズ リミティド | レストレスレッグス症候群の治療のためのラサギリンの使用 |
WO2008079727A2 (en) * | 2006-12-22 | 2008-07-03 | Allergan, Inc. | Compositions comprising an pan-alpha-2 receptor agonist and an anticonvulsant for treating chronic pain |
US20110097393A1 (en) * | 2008-06-25 | 2011-04-28 | US WorldMeade, LLC | Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery |
MX347106B (es) | 2009-03-10 | 2017-04-12 | Euro-Celtique S A * | Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona. |
US20180264013A1 (en) * | 2010-07-08 | 2018-09-20 | Wellesley Pharmaceuticals, Llc | Composition and methods for treating sleep disorders |
CA2876203A1 (en) * | 2012-06-11 | 2013-12-19 | Psychogenics, Inc. | Use of eltoprazine in the treatment of motor and movement disorders associated with the treatment of parkinson's disease |
CN105517551A (zh) | 2013-07-23 | 2016-04-20 | 欧洲凯尔特公司 | 用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合 |
KR101891185B1 (ko) | 2013-10-07 | 2018-08-24 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물 |
US20150098997A1 (en) | 2013-10-07 | 2015-04-09 | Teikoku Pharma Usa, Inc. | Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions |
RU2018105761A (ru) | 2013-10-07 | 2019-02-26 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Устройства для трансдермальной доставки дексмедетомидина и способы их применения |
WO2018052926A1 (en) * | 2016-09-13 | 2018-03-22 | Mindlab LLC | Medicine combinations and treatment of restless leg syndrome |
PT3906927T (pt) * | 2020-05-04 | 2022-07-27 | Bioprojet Pharma | Utilização de agonistas parciais da dopamina d3 para o tratamento de distúrbios do sistema nervoso central |
CN115154448B (zh) * | 2022-08-04 | 2024-01-30 | 谭竞 | 一种治疗不宁腿综合征的药物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859685A (en) * | 1986-08-13 | 1989-08-22 | Boc, Inc. | Anesthetic composition and method of using the same |
DE19758564A1 (de) * | 1997-11-11 | 1999-08-26 | Gruenenthal Gmbh | Formulierung einer Kombination aus Morphin und einem alpha¶2¶-adrenergem Agonisten und deren Verwendung |
SE9803760D0 (sv) * | 1998-11-04 | 1998-11-04 | Jan Hedner | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
AU3490300A (en) * | 1999-03-12 | 2000-10-04 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
-
1999
- 1999-08-19 DE DE19938823A patent/DE19938823A1/de not_active Withdrawn
-
2000
- 2000-08-09 WO PCT/EP2000/007719 patent/WO2001013903A2/de not_active Application Discontinuation
- 2000-08-09 CN CN00811555A patent/CN1368878A/zh active Pending
- 2000-08-09 JP JP2001518041A patent/JP2003513014A/ja active Pending
- 2000-08-09 IL IL14764300A patent/IL147643A0/xx unknown
- 2000-08-09 CZ CZ2002516A patent/CZ2002516A3/cs unknown
- 2000-08-09 AU AU68365/00A patent/AU6836500A/en not_active Abandoned
- 2000-08-09 BR BR0013355-8A patent/BR0013355A/pt active Pending
- 2000-08-09 MX MXPA02001295A patent/MXPA02001295A/es unknown
- 2000-08-09 SK SK245-2002A patent/SK2452002A3/sk unknown
- 2000-08-09 KR KR1020027002101A patent/KR20020020273A/ko not_active Application Discontinuation
- 2000-08-09 EP EP00956413A patent/EP1210076A2/de not_active Withdrawn
- 2000-08-09 PL PL00364871A patent/PL364871A1/xx not_active Application Discontinuation
- 2000-08-09 CA CA002382648A patent/CA2382648A1/en not_active Abandoned
- 2000-08-09 TR TR2002/00450T patent/TR200200450T2/xx unknown
- 2000-08-16 UY UY26296A patent/UY26296A1/es not_active Application Discontinuation
- 2000-08-17 PE PE2000000835A patent/PE20010738A1/es not_active Application Discontinuation
- 2000-08-18 AR ARP000104291A patent/AR025329A1/es active Pending
- 2000-08-18 CO CO00062316A patent/CO5190708A1/es not_active Application Discontinuation
-
2001
- 2001-08-01 US US09/919,731 patent/US20010053777A1/en not_active Abandoned
-
2002
- 2002-02-18 NO NO20020792A patent/NO20020792D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR200200450T2 (tr) | 2002-08-21 |
PE20010738A1 (es) | 2001-07-16 |
CZ2002516A3 (cs) | 2002-05-15 |
NO20020792L (no) | 2002-02-18 |
AU6836500A (en) | 2001-03-19 |
CA2382648A1 (en) | 2001-03-01 |
WO2001013903A2 (de) | 2001-03-01 |
IL147643A0 (en) | 2002-08-14 |
DE19938823A1 (de) | 2001-02-22 |
NO20020792D0 (no) | 2002-02-18 |
CO5190708A1 (es) | 2002-08-29 |
PL364871A1 (en) | 2004-12-27 |
JP2003513014A (ja) | 2003-04-08 |
US20010053777A1 (en) | 2001-12-20 |
AR025329A1 (es) | 2002-11-20 |
BR0013355A (pt) | 2002-04-30 |
WO2001013903A3 (de) | 2001-08-23 |
CN1368878A (zh) | 2002-09-11 |
SK2452002A3 (en) | 2002-06-04 |
KR20020020273A (ko) | 2002-03-14 |
MXPA02001295A (es) | 2002-08-12 |
EP1210076A2 (de) | 2002-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26296A1 (es) | Tratamiento medicamentoso del síndrome de piernas inquietas | |
ECSP003652A (es) | TRATAMIENTO DE COMBINACION CON I1-1ra Y COMPUESTOS QUE INHIBEN EL PROCESAMIENTO Y LA LIBERACION DE I1-1 | |
UY27598A1 (es) | Composiciones farmacéuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada | |
AR046510A1 (es) | Composicion de un antagonista de vegf y un agente anti-proliferativo | |
AR048210A1 (es) | Un agente preventivo para la vasculitis. | |
DK1143989T3 (da) | Exendiner til glucagonundertrykkelse | |
GT200600028A (es) | Compuestos y composiciones como inhibidores de proteina kinasa | |
PA8680701A1 (es) | Derivados de oxindol | |
ES2156603T3 (es) | Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. | |
ECSP034629A (es) | Combinacion de agonista de gaba e inhibidores de aldosa-reductasa | |
UY26293A1 (es) | "combinación de sustancias activas con clonidina." | |
PA8597501A1 (es) | Derivados azabiciclicos de piridiloximetilo y bencisoxazol | |
UY27401A1 (es) | Método para el tratamiento del insomnio primario | |
WO2003105751A3 (en) | NEW CURCUMIN DERIVATIVES | |
AR046853A1 (es) | Mezclas insecticidas que contienen triflumuron con actividad sinergica | |
AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables | |
ECSP003622A (es) | Tratamiento medicamentoso del sindrome de piernas inquietas | |
AR043016A2 (es) | Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene | |
SE0000303D0 (sv) | Novel compounds | |
ES2196171T3 (es) | Agentes antitumorales de tioxantenona liofilizada. | |
SE0203817D0 (sv) | New composition | |
AR027677A1 (es) | Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer | |
AR048355A1 (es) | Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen | |
ATE406880T1 (de) | Behandlung von motorischen veränderungen mit 5- hydrxoytryptamin 1a rezeptor aktivität verstärkenden wirkstoffen | |
AR027152A1 (es) | Composicion farmaceutica para el tratamiento de la enfermedad cerebrovascular cognitiva. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20110505 |